Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1905 of 6351
-
Earpiece could cut morphine use for Opioid-Dependent newborns
Symptom relief OngoingThe objective of this study is to determine if tAN therapy can reduce the median number of days of oral morphine administered to an infant after start of treatment.
Sponsor: Spark Biomedical, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Weight-Loss drug semaglutide put to the test on appetite control
Disease control CompletedThis study will evaluate the effect of semaglutide on eating behavior, appetite (hunger/fullness), and food liking in the long-term, as compared to placebo. All participants will receive lifestyle modification (diet and exercise) counseling, and will be prescribed the FDA-approve…
Phase 4 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New mRNA boosters aim to outsmart omicron variants
Vaccine CompletedThe purpose of this clinical trial is to learn about the safety, tolerability and immunogenicity of BNT162b RNA-based SARS-CoV-2 vaccine candidates in adults to prevent COVID-19. For all cohorts (groups of participants), this study is seeking participants who are healthy (who ma…
Phase 2/3 • Sponsor: BioNTech SE • Aim: Vaccine
Last updated Jun 27, 2026 07:52 UTC
-
Could a common supplement ease heart strain in kids with sickle cell?
Disease control CompletedThis study aims to investigate the possible efficacy and safety of L-Arginine in children having Sickle Cell Disease with increased Tricuspid Regurgitant Jet Velocity
Phase 3 • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Gene mapping could open new doors for brain tumor patients
Knowledge-focused CompletedIn Dutch centers performing neurosurgery on and/or treating GBM, all recurrent GBM patients are discussed in local tumor boards and this setup will be used to effectively identify possible GLOW study candidates. 160 patients that will undergo re-resection in the GLOW study will b…
Sponsor: UMC Utrecht • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Could leptospirosis leave lasting damage? a new study investigates
Knowledge-focused CompletedLeptospirosis is a zoonosis caused by spirochetes, pathogenic bacteria of the genus Leptospira. It is transmitted to humans through mucocutaneous lesions by contact with water or soil contaminated by the urine of animal reservoirs (rats, dogs, pigs, cattle, etc.). Exposure to fre…
Sponsor: Centre Hospitalier Universitaire de la Réunion • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
New Shockwave-Stent combo tackles tough leg artery blockages
Disease control CompletedThe objective of this clinical investigation is to evaluate, in a controlled setting, the 12 months safety and efficacy of the combination of Shockwave Intravascular Lithotripsy and a polymer coated Drug Eluting Stent device, for PACSS 3 and PACSS 4 calcified femoropopliteal dise…
Sponsor: Marc Bosiers, MD • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Heavier psoriasis patients may need a stronger dose of brodalumab
Disease control CompletedThis study investigates if an adjusted brodalumab dosage regimen will give improved efficacy in psoriasis in patients with a body weight of over 120 kg. The increased dosage regimen will be compared to the standard brodalumab treatment plus placebo.
Phase 4 • Sponsor: LEO Pharma • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for kids with rare Muscle-Weakening disease?
Disease control Recruiting nowThe purpose of this study is to determine the effect of nipocalimab on total serum immunoglobulin G (IgG) in pediatric participants 2 to less than (\<) 18 years of age (globally) and 8 to \<18 years of age (for Unites Stated (US) sites only), the safety and tolerability of treatm…
Phase 2/3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New couples program aims to ease emotional toll of stroke
Symptom relief OngoingAffecting nearly 800,000 people in the US every year, stroke is a leading cause of long-term disability, and has serious consequences for stroke survivors and their carepartners. Our project uses a scientifically rigorous efficacy study to evaluate a remotely delivered 8-week dya…
Sponsor: University of Utah • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Cord blood cells engineered to fight lung cancer enter human testing
Disease control OngoingThis phase I trial studies the side effects and best dose of COH06 with or without atezolizumab in patients with non-small cell lung cancer previously treated with PD-1 and/or PD-L1 immune checkpoint inhibitors that has spread to other places in the body (advanced) and that has n…
Phase 1 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Could a breath of CO2 save Stroke-Damaged brain tissue?
Disease control Recruiting nowAcute ischemic stroke due to large vessel occlusion is responsible of cerebral blood flow impairment with a progressive and extensive ischemic process. Cerebral collateral circulation may preserve an ischemic penumbra that could recover providing timely reperfusion of the occlude…
Phase 2 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New study aims to boost addiction treatment access in communities hardest hit by opioid overdoses
Disease control OngoingThe main goal of this current study is to develop and optimize methods for increasing access to, uptake of, and engagement in MAT (Medication Assisted Treatment) among communities of color.
Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New drug aims to soften skin in rare autoimmune disease
Disease control OngoingThe study will verify the superiority of MT-0551 to placebo at 26 weeks after treatment initiation in systemic sclerosis (SSc) patients using the modified Rodnan Total Skin thickness Score (mRTSS) as a measure of skin thickening. The safety and pharmacokinetics will also be inves…
Phase 3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Can telehealth boost HIV prevention in underserved communities?
Prevention CompletedTo evaluate if utilizing Telehealth medicine for access to HIV PrEP will engage more Black and Latino Men who have sex with Men (MSM)
Phase 4 • Sponsor: Vivent Health • Aim: Prevention
Last updated Jun 27, 2026 07:51 UTC
-
New drug combo aims to tackle tough lymphoma
Disease control OngoingThis is an open-label, multicentre study too Evaluate the Safety and Pharmacokinetics of a Modified Tafasitamab IV Dosing Regimen Combined with Lenalidomide (LEN) in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) who have had at least one, but no m…
Phase 1/2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New bird flu booster shot shows promise in early trial
Vaccine CompletedThis is a Phase 2, randomized, multi-center study in approximately 300 adults who received 2 doses of aH5N1c or placebo in and completed the parent study V89\_18 in the \<65 years of age cohort. The study investigates whether two priming doses of MF59-adjuvanted H5N1 cell culture…
Phase 2 • Sponsor: Seqirus • Aim: Vaccine
Last updated Jun 27, 2026 12:33 UTC
-
Can a dissolving thread smooth away wrinkles?
Symptom relief CompletedThe clinical trial, sponsored by Sutura Medical Technology, Inc., is a pivotal, blinded, multi-center study assessing the safety and effectiveness of the Demetech Barbed PDO Suture, an absorbable Polydioxanone suture, for the temporary treatment of midface wrinkles. The trial wil…
Sponsor: Sutura Medical Technology LLC • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Can a specialized massage outperform classic techniques for migraine sufferers?
Symptom relief CompletedThe study aims to compare the effects of connective tissue massage on pain severity, attack frequency and duration, migraine-related disability, and quality of life in patients diagnosed with migraine, by comparing them with the classical massage.
Sponsor: Biruni University • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
New drug aims to stop nosebleeds in rare genetic disorder
Disease control OngoingPart I: The purpose of this Phase 1b proof of concept study, randomised, placebo controlled, double blind, multicentre study is to asssess safety and efficacy of 2 doses of VAD044 in adult HHT patients. Part II: The purpose of this open-label extension following the completion o…
Phase 1/2 • Sponsor: Vaderis Therapeutics AG • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC